EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

The effect of higher versus lower wattage e‐cigarettes on smoking: A randomized controlled trial

Yoo Jin Cho iD, Alice Hinton, Jean Nshimiyimana, Toral Mehta, Lurdes Queimado, Irina Stepanov, Samantha Case, Laura A Beebe, Theodore L Wagener iD

Addiction · 2026

DOI: 10.1111/add.70421 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Addiction, 2026. Verfasst von Yoo Jin Cho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tobacco Research, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Smoking Cessation, Cigarette Smoking. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institute on Drug Abuse of the NIH, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To assess whether higher wattage e‐cigarettes (HWe), with improved nicotine delivery, enhance complete substitution compared with lower wattage e‐cigarettes (LWe) and whether complete switching lowers exposure to a cigarette‐derived lung carcinogen, using urinary 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL) as a biomarker.

Design

A 3‐arm randomized controlled trial with a 12‐week treatment period and follow‐ups at 26 and 52 weeks. Participants were enrolled from June 2017 to December 2022, with all visits completed by March 2023.

Setting

Academic medical centers in the United States.

Participants

372 adults who smoked and were not interested in quitting [mean age = 40 years; standard deviation (SD) = 11.0; 63% female; mean cigarettes per day = 17; SD = 8.9] were randomized and comprised the analytic sample.

Intervention

A 12‐week supply of HWe, LWe or usual brand cigarettes (UBC).

Measurements

The primary outcome was between‐group differences in complete substitution rates at week 12, defined as self‐reported smoking of 1 or fewer cigarettes in the past 7 days [confirmed by exhaled carbon monoxide (eCO) < 4 ppm], with missing data imputed as smoking, and self‐reported use of e‐cigarettes during the 7‐day period. Additional outcomes included urinary NNAL through week 12.

Findings

At 12 weeks, complete substitution rates were 6.0% (8 of 134) with HWe and 9.0% (12 of 133) with LWe, with no statistically significant between‐group difference. Complete substitution rates were 3.7% (HWe) vs. 9.0% (LWe) at 26 weeks, and 4.5% vs. 5.3% at 52 weeks, with no statistically significant between‐group differences. Among those who completely switched, mean NNAL levels decreased over 12 weeks with both LWe [mean decrease: 2.4 pmol/mg creatinine; 95% confidence interval (CI) = 1.2–3.7; P = 0.002] and HWe (mean decrease: 2.3 pmol/mg creatinine; 95% CI = 1.1–3.6; P = 0.002).

Conclusions

Provision of higher and lower wattage e‐cigarettes to adults who smoked and were not interested in quitting resulted in comparable substitution rates. Complete switching from cigarettes to higher and lower wattage e‐cigarettes reduced urinary 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electronic Nicotine Delivery SystemsSmoking CessationCigarette SmokingHumansFemaleNitrosaminesAdultMaleNicotinePyridinesMiddle Aged

Substanzen

Nitrosamines4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-olNicotinePyridines

Autor:innen und Institutionen

  • Center for Tobacco Research, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Department of Internal Medicine, College of Medicine, Ohio State University, Columbus, OH, USA.
  • Division of Biostatistics, College of Public Health, Ohio State University, Columbus, OH, USA.
  • TSET Health Promotion Research Center, Stephenson Cancer Center and Department of Otolaryngology Head and Neck Surgery, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.

ORCID-Profile: Yoo Jin Cho, Theodore L Wagener

Förderung

  • NCI NIH HHS
  • National Institute on Drug Abuse of the NIH
  • NIDA NIH HHS
  • National Cancer Institute (NCI)
  • National Institute on Drug Abuse (NIDA)
  • Division of Cancer Prevention, National Cancer Institute

Zitieren

APA

Cho, Y. J., Hinton, A., Nshimiyimana, J., Mehta, T., Queimado, L., Stepanov, I., Case, S., Beebe, L. A., & Wagener, T. L. (2026). The effect of higher versus lower wattage e‐cigarettes on smoking: A randomized controlled trial. Addiction. https://doi.org/10.1111/add.70421

Vancouver

Cho YJ, Hinton A, Nshimiyimana J, Mehta T, Queimado L, Stepanov I, et al. The effect of higher versus lower wattage e‐cigarettes on smoking: A randomized controlled trial. Addiction. 2026. doi:10.1111/add.70421

BibTeX
@article{Cho2026,
  author = {Cho, Yoo Jin and Hinton, Alice and Nshimiyimana, Jean and Mehta, Toral and Queimado, Lurdes and Stepanov, Irina and Case, Samantha and Beebe, Laura A and Wagener, Theodore L},
  title = {The effect of higher versus lower wattage e‐cigarettes on smoking: A randomized controlled trial},
  journal = {Addiction},
  year = {2026},
  doi = {10.1111/add.70421}
}
Kostenlos starten →